Evaluation of antiviral treatment response on liver histopathology in chronic hepatitis B infection patients

被引:0
作者
Karacaer, Zehra [1 ]
Diktas, Husrev [2 ]
机构
[1] Etimesgut Mil Hosp, Dept Infect Dis & Clin Microbiol, Ankara, Turkey
[2] Tatvan Mil Hosp, Dept Infect Dis & Clin Microbiol, Bitlis, Turkey
关键词
TENOFOVIR DISOPROXIL FUMARATE; REGRESSION; CIRRHOSIS;
D O I
10.5152/tjg.2015.0409
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:83 / 84
页数:2
相关论文
共 50 条
  • [21] The Host Response to Chronic Hepatitis B Infection
    Cringus, Laura-Ioana
    Petrescu, Florin
    Calborean, Veronica
    Rotaru, Luciana Teodora
    Marginean, Cristina
    Mesina, Cristian
    Bunescu, Marius Gabriel
    Dinescu, Venera Cristina
    Gheorman, Victor
    Dijmarescu, Anda Lorena
    Udristoiu, Ion
    Ciobanu, Daniela
    REVISTA DE CHIMIE, 2019, 70 (02): : 646 - 650
  • [22] Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance
    Zoulim, Fabien
    Locarnini, Stephen
    LIVER INTERNATIONAL, 2013, 33 : 116 - 124
  • [23] The LAW index as an accurate indicator of the initiation of antiviral treatment in patients with chronic hepatitis B
    Lee, Jae Min
    Seo, Yeon Seok
    Kim, Tae Hyung
    Ahn, Jem Ma
    Yim, Sun Young
    Kim, Seung Up
    Jung, Young Kul
    Kim, Ji Hoon
    An, Hyunggin
    Yim, Hyung Joon
    Yeon, Jong Eun
    Lee, Hong Sik
    Byun, Kwan Soo
    Um, Soon Ho
    Kim, Chang Duck
    Ryu, Ho Sang
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (01) : 208 - 214
  • [24] Gaps and disparities in the treatment of chronic hepatitis B infection in the USA
    Wong, Robert J.
    GASTROENTEROLOGY REPORT, 2025, 13
  • [25] Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections
    De Clercq, Erik
    Ferir, Geoffrey
    Kaptein, Suzanne
    Neyts, Johan
    VIRUSES-BASEL, 2010, 2 (06): : 1279 - 1305
  • [26] Antiviral treatment for chronic hepatitis B: Safety, effectiveness, and prognosis
    Wu, Ya-Li
    Shen, Cheng-Li
    Chen, Xin-Yue
    WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (14) : 1784 - 1794
  • [27] Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection
    Hsu, Ching-Sheng
    Liu, Wei-Liang
    Chao, You-Chen
    Lin, Hans Hsienhong
    Tseng, Tai-Chung
    Wang, Chia-Chi
    Chen, Ding-Shinn
    Kao, Jia-Horng
    HEPATOLOGY INTERNATIONAL, 2015, 9 (02) : 231 - 242
  • [28] Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B
    Wong, Grace Lai-Hung
    Chan, Henry Lik-Yuen
    Tse, Yee-Kit
    Yip, Terry Cheuk-Fung
    Lam, Kelvin Long-Yon
    Lui, Grace Chung-Yon
    Wong, Vincent Wai-Sun
    JOURNAL OF HEPATOLOGY, 2018, 69 (04) : 793 - 802
  • [29] Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B
    Xu, Bei
    Lin, Lanyi
    Xu, Guoguang
    Zhuang, Yan
    Guo, Qing
    Liu, Yunye
    Wang, Hui
    Zhou, Xiaqiu
    Wu, Shanming
    Bao, Shisan
    Cai, Wei
    Xie, Qing
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (02) : 372 - 378
  • [30] Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis
    Okada, Masako
    Enomoto, Masaru
    Kawada, Norifumi
    Nguyen, Mindie H.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (12) : 1095 - 1104